37 related articles for article (PubMed ID: 12818196)
1. A common protein C inhibitor exosite partially controls the heparin induced activation and inhibition of serine proteases.
Siddiqui U; Khan AB; Ahmad T; Rehman AA; Jairajpuri MA
Int J Biol Macromol; 2024 May; 266(Pt 2):131065. PubMed ID: 38521329
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the multiple functions of protein C inhibitor.
Huntington JA; Li W
Cell Mol Life Sci; 2009 Jan; 66(1):113-21. PubMed ID: 18818878
[TBL] [Abstract][Full Text] [Related]
3. Suggestions on leading an academic research laboratory group.
Church FC
Open Life Sci; 2022; 17(1):599-609. PubMed ID: 35800075
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke.
Andreou AP; Efthymiou M; Yu Y; Watts HR; Noormohamed FH; Ma D; Lane DA; Crawley JT
PLoS One; 2015; 10(4):e0122410. PubMed ID: 25830552
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C action in inflammation.
Sarangi PP; Lee HW; Kim M
Br J Haematol; 2010 Mar; 148(6):817-33. PubMed ID: 19995397
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the human lung proteome with lipopolysaccharide.
Bowler RP; Reisdorph N; Reisdorph R; Abraham E
BMC Pulm Med; 2009 May; 9():20. PubMed ID: 19432985
[TBL] [Abstract][Full Text] [Related]
7. Distinct functions of activated protein C differentially attenuate acute kidney injury.
Gupta A; Gerlitz B; Richardson MA; Bull C; Berg DT; Syed S; Galbreath EJ; Swanson BA; Jones BE; Grinnell BW
J Am Soc Nephrol; 2009 Feb; 20(2):267-77. PubMed ID: 19092124
[TBL] [Abstract][Full Text] [Related]
8. Serpins in thrombosis, hemostasis and fibrinolysis.
Rau JC; Beaulieu LM; Huntington JA; Church FC
J Thromb Haemost; 2007 Jul; 5 Suppl 1(Suppl 1):102-15. PubMed ID: 17635716
[TBL] [Abstract][Full Text] [Related]
9. Is protein C inhibitor antithrombotic and protective in pulmonary hypertension?
Beaulieu LM; Church FC
J Thromb Haemost; 2006 Nov; 4(11):2327-30. PubMed ID: 16981887
[No Abstract] [Full Text] [Related]
10. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor activator (HGFA): its regulation by protein C inhibitor.
Suzuki K
FEBS J; 2010 May; 277(10):2223-9. PubMed ID: 20402764
[TBL] [Abstract][Full Text] [Related]
12. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
[TBL] [Abstract][Full Text] [Related]
13. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
Shen L; Dahlbäck B; Villoutreix BO
Biochemistry; 2000 Mar; 39(11):2853-60. PubMed ID: 10715104
[TBL] [Abstract][Full Text] [Related]
14. Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C.
Friedrich U; Blom AM; Dahlbäck B; Villoutreix BO
J Biol Chem; 2001 Jun; 276(26):24122-8. PubMed ID: 11316800
[TBL] [Abstract][Full Text] [Related]
15. Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C.
Yang L; Manithody C; Rezaie AR
Biochemistry; 2002 May; 41(19):6149-57. PubMed ID: 11994010
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
